Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Buzz on the Bullboards: Stocks making headlines - Baytex, New Found Gold, Theralase

After a tough two-day drop, Canada’s main stock index rallied on Wednesday following reports that the US administration was considering relaxing the strict tariffs on imports from Canada and Mexico. What the “Buzz” ...

ImmunoGen Shares Rise 25% on FY/19 Financial Results and Clinical Pipeline Updates

Shares of ImmunoGen Inc. reached a new 52-week intraday high price after the company announced FY/19 financial results and reported on recent developments including the completion of a $97.6 million capital raise in January 2020. Clinical-stage biotechnology...

A potential breakthrough in spinal cord and optic nerve injury treatment

Click Here to Download the Full Report This is third-party provided content issued on behalf of NurExone Biologic Inc., please see full disclaimer here .

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-20...

First Helium Highlighting its Immediate Helium Opportunity

Welcome to the Market Herald Video Q&A podcast. I’m Brieanna McCutcheon.Ed Bereznicki is the President and CEO of First Helium and has joined us today to give us a brief update on ongoing and...

Allakos Shares Double on AK002 Phase 2 Results and Earnings

Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. Clinical stage biotech company Allak...

Revolutionizing Mental Health Treatment

(Click to play video.) Cybin Inc. ( NEO: CYBN , NYSE: CYBN , Forum ) is a Toronto-based life sciences company initially focused on psychedelic pharmaceutical therapies supporting research to advance psychedelic therapies centered on improving mental health and...

Buzz on the Bullboards: Top Talked About Stocks During Volatile Times

(Image via Tilray Inc.) A leading global cannabis-lifestyle and consumer packaged goods company, Tilray Inc. ( NASDAQ: TLRY , Forum ) has operations in Canada, the United States, Europe, Australia, and Latin America. SweetWater Brewing Company , a subsidiary o...

When the levee breaks

In George Steinbeck’s epic novel ‘The Grapes of Wrath’, a poor family of tenant farmers and thousands of other “Oakies” hitch up their wagons to make the trek to California in search of work and a better life. A savage dr...

A “Forward” Thinking Solution to the Way Industry Handles Wastewater

(Click image to play video.) Finding practical and long-term solutions to water sustainability is one of the planet’s most pressing needs. And one of the greatest challenges facing humanity in the 21 st century is access to abundant, clean water...
1 2 3 4 5 6 7 8 9 10 ...